According to the DEP network interaction analysis, epimedin C alleviated T2DM and regulated lipid metabolism partially by increasing the expression levels of Pla2g12b, Cyp4a14, and Apob and decreasing the expression level of Pck1 in the livers of T2DM mice. The gene discussed is PCK1; the disease is type 2 diabetes mellitus.